An interventional study of Dyadic lifestyle intervention for CVD risk reduction in Hypertension (HTN), sponsored by University of Alabama at Birmingham. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-12.
Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 44 studies in Hypertension by University of Alabama at Birmingham — 13 open to participants now, 16 under way, 1 of them phase 3. Hypertension · University of Alabama at Birmingham.
Among the 44 studies in Hypertension by University of Alabama at Birmingham, this one is the 18th largest by planned enrollment of the 38 interventional ones that give a count, is one of 7 that started in 2026, is one of 29 with no phase, reaches primary completion later than 4 of the 15 other live ones, and was the 42nd registered.
6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.
Browse Hypertension studies →13 of the 44 studies in Hypertension by University of Alabama at Birmingham are open now, in 1 country. Recruiting first, the newest first:
University of Alabama at Birmingham · Sites in United States
Ages 16–56 · Women only
University of Alabama at Birmingham · Sites in United States
Ages 60+
University of Alabama at Birmingham · Sites in United States
Ages 30–79 · Women only
University of Alabama at Birmingham · Sites in United States
Ages 18–55
University of Alabama at Birmingham · Sites in United States
Ages 18–89
By country, each count listing its studies:
Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
44 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 4 · Phase 3 2 · Phase 4 3
First in 1995; this study’s year is marked. 7 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 85 is below the median of 100 across 4,585 interventional studies indexed under Hypertension.
Median enrollment 71 across the 38 interventional studies, 378 across the 6 observational. Of the 27 that completed or were terminated, 9 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Alabama at Birmingham is the lead sponsor of 1,422 studies on the registry; 277 are open to participants now.
Of its 164 completed or terminated interventional studies of FDA-regulated products, 130 (79%) have results posted.
2 of the studies in Hypertension by University of Alabama at Birmingham that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04971720Phase 3University of Alabama at BirminghamPRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis | 2027-01-01 |
| NCT07760350University of Alabama at BirminghamAssessing the Feasibility of the "Heart Care Pairs" Intervention | 2027-05-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 44 studies in Hypertension by University of Alabama at Birmingham, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The researchers will invite 30 patients in primary care who have high blood pressure to participate in this health program with a supportive partner of their choosing (these will be the "participant pairs"). Participant pairs will be invited to complete the Heart Care Pairs health program that will include up to six sessions each including 1) some education on a health habit like physical activity and heart healthy foods, 2) goal setting together, and 3) talk about healthy communication to support one another with heart healthy habits. The researchers will work with participants to address things that get in the way of coming for visits like offering transportation and offering telehealth visits. The researchers are seeing how this program works in real life so participants will be asked to complete as many sessions as they want to and can attend. The researchers will be interested in what participants think about the sessions, if they were satisfied with the visits, and if they would recommend the program to others in their community. The researchers will ask these questions in interviews with participants. The researchers will also ask up to 25 primary care workers about how they view the program as helpful to their work with patients with high blood pressure and whether they would refer more patients to the program in the future.
The overall objective of the present pilot behavioral trial is to assess the feasibility and acceptability of a dyadic CVD risk reduction intervention to be delivered by behavioral health consultants in primary care practices for patients with HTN. In a preliminary investigation prior to this pilot project, the research team has confirmed feasibility of recruitment of dyads from primary care settings, assessed health and social support needs, and interest in an intervention like Heart Care Pairs while making ongoing systematic adaptations to the intervention. The next phase of pilot work outlined in this proposal will assess if the intervention will work in primary care by assessing retention, treatment process, and acceptability.
Aim 1: To determine the feasibility and acceptability of the Heart Care Pairs intervention with N=30 dyads including patients with HTN attending primary care and their chosen supportive partner using a mixed methods single-arm pragmatic trial.
Hyp 1: Heart Care Pairs will be feasible based on dyads attending \<70% of intervention sessions, completion of follow-up assessments and interviews, and overall patient- and partner-reported satisfaction with the intervention.
Aim 2: To assess primary care workflow and PCP acceptability of making referrals to a dyadic behavioral health intervention.
Hyp 2: PCPs will agree that they referred patients to the Heart Care Pairs intervention and that the availability of the referral is helpful for their practice.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Dyadic lifestyle intervention for CVD risk reduction "Heart Care Pairs"
Behavioral: Dyadic lifestyle intervention for CVD risk reduction
This is a 6-session behavioral intervention delivered in primary care. The 6 educational topics include: 1) DASH diet; 2) Physical activity; 3) Stress management; 4) Healthy sleep habits; 5) Substance cessation (optional); 6) Adherence to medications and lifestyle habits. All sessions will include collaborative goal setting. And each educational topic will be paired with a communication skill: 1) Seeing others' perspectives; 2) Minimize efforts to control; 3) Non-judgmental language; 4) Support movement towards change; 5) Addressing relapse; and 6) Empathetic responding and self-advocacy.
Completion of follow-up assessments
Number of surveys and interviews completed
Time frame: Immediately post-intervention
Time to complete recruitment
Time from posting recruitment materials to enrollment of 30 dyads
Time frame: From study start to end of recruitment, an average of 6 months
Responsiveness to change on survey measures
Change scores between baseline assessment to follow-up assessment
Time frame: Baseline to immediately post-intervention - approximately 12 weeks
Attendance to intervention sessions
Number of sessions attended compared to number of sessions missed
Time frame: Baseline to immediately post-intervention - approximately 12 weeks
Treatment Satisfaction Questionnaire
Participant ratings of satisfaction with the HCPs intervention. 9-items, with responses on a scale from 1-7. Some items assess satisfaction (1=extremely dissatisfied to 7=extremely satisfied), confidence (1=not at all confident, 7=extremely confident, certainty (1=not at all certain, 7=extremely certain), how easy to use/do the intervention was (1=extremely difficult, 7=extremely easy). Mean scores will be calculated for min score=1 and max score of 7. Higher scores indicate greater satisfaction, and lower burden with the intervention.
Time frame: Immediately post-intervention
Health-related quality of life (HRQoL)
1-item self-rated health status (Bullinger, 1996; Dumas, et al, 2020)
Time frame: Baseline and immediately post-intervention
Perceived Stress Scale - 10
10-item Perceived Stress Scale (PSS-10; Roberti, et al, 2006). Responses range from 0=Never to 4=Very often. Scores are summed for total perceived stress score ranging from 0-40 with higher scores meaning higher perceived stress.
Time frame: Baseline and immediately post-intervention
Smoking status
1-item cigarette smoking status and number cigarettes per day
Time frame: Baseline and immediately post-intervention
Patient Health Questionnaire - 9
PHQ-9 depression screen (Kroenke, et al, 2001). Respondents endorse symptoms of depression over the past 2 weeks on a scale from 0=not at all to 3=nearly everyday. Scores are summed for total scores ranging from 0 to 27 with higher scores indicating greater severity of depression symptoms.
Time frame: Baseline and immediately post-intervention
Generalized anxiety disorder (GAD)-7
GAD-7 screen for anxiety symptoms (Spitzer, et al., 2006). Respondents endorse symptoms of anxiety over the past 2 weeks on a scale from 0=not at all to 3=nearly everyday. Scores are summed for total scores ranging from 0 to 21 with higher scores indicating greater severity of anxiety symptoms.
Time frame: Baseline and immediately pot-intervention
Body mass index
Approximation of body size based on clinic measured height and weight
Time frame: Baseline and immediately post-intervention
Mediterranean Eating Pattern Assessment (MEPA)
Brief assessment of heart healthy eating, self-report recall for past week,16 items. Items assess self-reported number of servings per type of food in the past week. Items are scored based on thresholds meeting a mediterranean diet eating pattern (e.g., greater than or equal to 2 servings of vegetables per day). Scores range from 0-16 with higher scores being more adherent to mediterranean diet pattern (more heart healthy diet).
Time frame: Baseline and immediately post-intervention
International physical activity questionnaire short form (IPAQ-SF)
Self-reported walking, moderate physical activity, vigorous physical activity, and sedentary time, 7-items (Lee, et al, 2011). Total met minutes are calculated for each activity domain. Walking MET minutes = 3.3\*walking days\* walking minutes. Moderate MET minutes = 4.0\*moderate days\*moderate minutes. Vigorous MET minutes=8.0\*vigorous days\*vigorous minutes. Total MET minutes = Waling MET min+Moderate MET min+Vigorous MET min.
Time frame: Baseline and immediately post-intervention
Sleep time
1-item total average sleep time (Lloyd-Jones, et al, 2022)
Time frame: Baseline and immediately post-intervention
Adherence self-report questionnaire (ASRQ)
Self reported medication adherence to blood pressure medicines (Zeller, et al., 2008) 1-item with 1=take all BP medications at the same time every day (excellent adherence) to 6=Hardly take any BP medications (poor adherence).
Time frame: Baseline and immediately post-intervention
Treatment Self Regulation Questionnaire
Measure of autonomy, self-report 19-tems (Levesque, et al, 2007). 19-items assessed using a Likert-type scale from 1=Not at all true to 7=Very true. Mean of scores will be calculated with higher score meaning greater autonomy over heart healthy behaviors (taking medications, healthy diet, exercise).
Time frame: Baseline and immediately post-intervention
Important other climate questionnaire
Measure of autonomy support, self-report 6-items (Williams, 2006). Responses are on a Likert Scale. Mean scores will be calculated with higher scores indicating greater support from "important others" with efforts to lower blood pressure.
Time frame: Baseline and immediately post-intervention
Social Support for Diet and Exercise Behaviors
Social support from family, friends, supportive other related to healthy diet and exercise behavior (Sallis, et al., 1987). Responses range from 0=Rarely to 3=very often. Each question will be asked for "Family," "Friends," and "Study Partner." Mean scores for each relationship type will be calculated with higher scores indicate greater support with health behavior.
Time frame: Baseline and immediately post-intervention
Medical Outcomes Study (MOS) Social Support Survey
A total of 19-items self-report for measures of global social support and subscales for: emotional/informational, tangible, affectionate, and positive social interaction. Responses to items range from 1=none of the time to 5=all of the time. The mean items responses are taken for each subscale with higher scores meaning greater social support (Sherbourne \& Stewart, 1991)
Time frame: Baseline and immediately post-intervention
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for May 2027, 6 months later.
Of 1,407 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 6 months is below that.
Counting every sponsor, half of 1,502 studies reached it within 23 months; a quarter within 10 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Alabama at Birmingham →